Search

Anglis Briggs Phones & Addresses

  • 158 Woodshade Dr, Newark, DE 19702 (302) 731-7498
  • Wilmington, DE
  • 158 Woodshade Dr, Newark, DE 19702

Publications

Us Patents

Serum And Plasma Clarification Process

View page
US Patent:
42644712, Apr 28, 1981
Filed:
Jun 4, 1979
Appl. No.:
6/045182
Inventors:
Anglis R. Briggs - Newark DE
Assignee:
E. I. Du Pont de Nemours and Company - Wilmington DE
International Classification:
G01N 3348
G01N 3392
US Classification:
252408
Abstract:
A process for obtaining delipified human serum or plasma of low turbidity, and therefore decreased light scattering, is provided. This process comprises the simultaneous steps of deionization and pH adjustment of the serum or plasma to near the isoelectric point of lipoproteins commonly found in sera and results in the precipitation of much of the lipoprotein fraction. The process is carried out utilizing a mixed anion-cation exchange resin. The sera so obtained can be used as base material or a special diluent for verifying analytical information obtained in clinical analyses.

Monothioglycerol As Thiol-Protector In Lyophilized Materials

View page
US Patent:
44422121, Apr 10, 1984
Filed:
Nov 10, 1980
Appl. No.:
6/205793
Inventors:
Anglis R. Briggs - Newark DE
Assignee:
E. I. Du Pont de Nemours & Company - Wilmington DE
International Classification:
C12N 996
US Classification:
435188
Abstract:
A lyophilized product containing monothioglycerol, sulfhydryl-requiring enzyme and a specially prepared serum matrix, useful in the clinical laboratory when reconstituted, is provided.

Method Of Preparation Of Lyophilized Biological Products

View page
US Patent:
39329437, Jan 20, 1976
Filed:
Aug 16, 1974
Appl. No.:
5/498326
Inventors:
Anglis R. Briggs - Newark DE
Thomas J. Maxwell - Philadelphia PA
Assignee:
E. I. Du Pont de Nemours and Company - Wilmington DE
International Classification:
F26B 506
US Classification:
34 5
Abstract:
Disclosed herein is a homogeneous, lyophilized particulate product of a substance containing at least one biologically active component and a process for its preparation which involves forming a solution or colloidal suspension of the substance, spraying the solution or colloidal suspension into a moving bath of fluorocarbon refrigerant and lyophilizing the resultant frozen droplets. The porous product has a spherical shape, free-flowing properties, and rapid dissolution times.
Anglis R Briggs from Newark, DEDeceased Get Report